The role of FXR and TGR5 in reversing and preventing progression of Western diet–induced hepatic steatosis, inflammation, and fibrosis in mice
Xiaoxin X. Wang(Beijing Obstetrics and Gynecology Hospital), Moshe Levi(University of Colorado Anschutz Medical Campus), Andrew E. Libby(Georgetown University), Komuraiah Myakala(Georgetown University), Stephen M. Hewitt(National Institutes of Health), Suman Ranjit(Georgetown University), David E. Kleiner(National Institutes of Health), Avi Z. Rosenberg(Johns Hopkins University), David J. Orlicky(University of Colorado Anschutz Medical Campus), Shogo Takahashi(National Cancer Institute), Diana Ir(University of Colorado Anschutz Medical Campus), Jeffrey B. Kopp(National Institute of Diabetes and Digestive and Kidney Diseases), Jonathan Levi(National Institutes of Health), Kanchan Bhasin(Georgetown University), Yuhuan Luo(University of Colorado Anschutz Medical Campus), Charles E. Robertson(Duke University), Luciano Adorini(Intercept Pharmaceuticals (United States)), Kristopher W. Krausz(National Institutes of Health), Daniel N. Frank(University of Colorado Anschutz Medical Campus), Frank J. Gonzalez(National Cancer Institute), James L. McManaman(University of Colorado Anschutz Medical Campus), Bryce A. Jones(Georgetown University), Cen Xie(Nanjing University of Chinese Medicine), Alexander Dvornikov(Fluor (United States)), Enrico Gratton(University of California, Irvine)
Cited by 55
Related Papers
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k
Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity
|Science|2013|2k
Lipid Rafts Reconstituted in Model Membranes
|Biophysical Journal|2001|1.4k
The Phasor Approach to Fluorescence Lifetime Imaging Analysis
|Biophysical Journal|2007|1.2k